1. Home
  2. RNW vs EVO Comparison

RNW vs EVO Comparison

Compare RNW & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNW
  • EVO
  • Stock Information
  • Founded
  • RNW 2011
  • EVO 1993
  • Country
  • RNW United Kingdom
  • EVO Germany
  • Employees
  • RNW N/A
  • EVO N/A
  • Industry
  • RNW Electric Utilities: Central
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNW Utilities
  • EVO Health Care
  • Exchange
  • RNW Nasdaq
  • EVO Nasdaq
  • Market Cap
  • RNW 2.4B
  • EVO 1.5B
  • IPO Year
  • RNW N/A
  • EVO 2021
  • Fundamental
  • Price
  • RNW $7.46
  • EVO $4.07
  • Analyst Decision
  • RNW Strong Buy
  • EVO Buy
  • Analyst Count
  • RNW 1
  • EVO 2
  • Target Price
  • RNW $7.50
  • EVO $5.90
  • AVG Volume (30 Days)
  • RNW 1.4M
  • EVO 113.1K
  • Earning Date
  • RNW 08-14-2025
  • EVO 08-13-2025
  • Dividend Yield
  • RNW N/A
  • EVO N/A
  • EPS Growth
  • RNW 16.07
  • EVO N/A
  • EPS
  • RNW 0.13
  • EVO N/A
  • Revenue
  • RNW $1,135,947,896.00
  • EVO $851,944,444.00
  • Revenue This Year
  • RNW N/A
  • EVO $10.08
  • Revenue Next Year
  • RNW $17.72
  • EVO $10.99
  • P/E Ratio
  • RNW $58.97
  • EVO N/A
  • Revenue Growth
  • RNW 19.36
  • EVO 1.50
  • 52 Week Low
  • RNW $5.15
  • EVO $2.84
  • 52 Week High
  • RNW $7.67
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • RNW 63.67
  • EVO 47.66
  • Support Level
  • RNW $7.41
  • EVO $4.12
  • Resistance Level
  • RNW $6.94
  • EVO $4.26
  • Average True Range (ATR)
  • RNW 0.17
  • EVO 0.11
  • MACD
  • RNW 0.06
  • EVO -0.01
  • Stochastic Oscillator
  • RNW 82.08
  • EVO 54.84

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: